Cargando…

Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers

ATP-dependent P2X3 receptors play a crucial role in the sensitization of nerve fibers and pathological pain pathways. They are also involved in pathways triggering cough and may contribute to the pathophysiology of endometriosis and overactive bladder. However, despite the strong therapeutic rationa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davenport, Adam J., Neagoe, Ioana, Bräuer, Nico, Koch, Markus, Rotgeri, Andrea, Nagel, Jens, Laux-Biehlmann, Alexis, Machet, Frederic, Coelho, Anne-Marie, Boyce, Susan, Carty, Nikisha, Gemkow, Mark J., Hess, Stephen D., Zollner, Thomas M., Fischer, Oliver M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494816/ https://www.ncbi.nlm.nih.gov/pubmed/34615939 http://dx.doi.org/10.1038/s41598-021-99177-0

Ejemplares similares

Discovery of BAY-390, a Selective CNS Penetrant Chemical Probe as Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonist
por: Mesch, Stefanie, et al.
Publicado: (2023)

Anxiety-related behaviors without observation of generalized pain in a mouse model of endometriosis
por: Nunez-Badinez, Paulina, et al.
Publicado: (2023)

First‐in‐human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics
por: Klein, Stefan, et al.
Publicado: (2022)

Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study
por: Friedrich, Christian, et al.
Publicado: (2022)

Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study
por: Dicpinigaitis, Peter V., et al.
Publicado: (2023)

Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
por: Morice, Alyn, et al.
Publicado: (2021)

Two Cases of H(2)-Receptor Antagonist Hypersensitivity and Cross-Reactivity
por: Song, Woo-Jung, et al.
Publicado: (2011)

TRPV1 antagonist attenuates postoperative hypersensitivity by central and peripheral mechanisms
por: Uchytilova, Eva, et al.
Publicado: (2014)

Lung Microbiota in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Unclassified Interstitial Lung Diseases: A Preliminary Pilot Study
por: Man, Milena Adina, et al.
Publicado: (2023)

Morphine Binds Creatine Kinase B and Inhibits Its Activity
por: Weinsanto, Ivan, et al.
Publicado: (2018)

Corrigendum: Morphine Binds Creatine Kinase B and Inhibits Its Activity
por: Weinsanto, Ivan, et al.
Publicado: (2019)

The Agonist-antagonist Myoneural Interface
por: Herr, Hugh, et al.
Publicado: (2021)

The T‐type calcium channel antagonist, Z944, reduces spinal excitability and pain hypersensitivity
por: Harding, Erika K., et al.
Publicado: (2021)

Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)

Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors
por: Jurga, Agnieszka M., et al.
Publicado: (2018)

Preclinical models of endometriosis and interstitial cystitis/bladder pain syndrome: an Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic pain
por: Nunez-Badinez, Paulina, et al.
Publicado: (2021)

Lithium reverses mechanical allodynia through a mu opioid-dependent mechanism
por: Weinsanto, Ivan, et al.
Publicado: (2018)

Amine oxidase 3 is a novel pro-inflammatory marker of oxidative stress in peritoneal endometriosis lesions
por: Thézénas, Marie-Laëtitia, et al.
Publicado: (2020)

Author Correction: Amine oxidase 3 is a novel pro-inflammatory marker of oxidative stress in peritoneal endometriosis lesions
por: Thézénas, Marie-Laëtitia, et al.
Publicado: (2020)

HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity
por: Eid, Samer R, et al.
Publicado: (2008)

Hypersensitive response and acyl‐homoserine lactone production of the fire blight antagonists Erwinia tasmaniensis and Erwinia billingiae
por: Jakovljevic, Vladimir, et al.
Publicado: (2008)

PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy
por: Armstrong, Chris W.D., et al.
Publicado: (2016)

Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist
por: Uchytilova, Eva, et al.
Publicado: (2021)

The incidence of skin lesions in contrast media-induced chemical hypersensitivity
por: Iordache, Andrei Mihai, et al.
Publicado: (2019)

Neutrophil extracellular traps are involved in enhanced contact hypersensitivity response in IL-36 receptor antagonist-deficient mice
por: Hasegawa, Yurie, et al.
Publicado: (2022)

Stress-Induced Visceral Hypersensitivity in Maternally Separated Rats Can Be Reversed by Peripherally Restricted Histamine-1-Receptor Antagonists
por: Stanisor, Oana I., et al.
Publicado: (2013)

H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?
por: Borro, Matteo, et al.
Publicado: (2021)

CRISPR/Cas9: A Potential Life-Saving Tool. What’s next?
por: Gulei, Diana, et al.
Publicado: (2017)

Combined Therapy in Cancer: The Non-coding Approach
por: Gulei, Diana, et al.
Publicado: (2018)

Activation of Necroptosis by Engineered Self Tumor-Derived Exosomes Loaded with CRISPR/Cas9
por: Gulei, Diana, et al.
Publicado: (2019)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Drug hypersensitivity in students from São Paulo, Brazil
por: Ensina, Luis Felipe Chiaverini, et al.
Publicado: (2010)

Delayed Hypersensitivity
por: Waksman, Byron H.
Publicado: (1968)

Hypersensitivity pneumonitis
por: Lacasse, Yves, et al.
Publicado: (2006)

Mechanisms of Hypersensitivity
por: Baldo, Brian A., et al.
Publicado: (2013)

Defective response inhibition and collicular noradrenaline enrichment in mice with duplicated retinotopic map in the superior colliculus
por: Mathis, Chantal, et al.
Publicado: (2014)

OCCURRENCE OF DELAYED HYPERSENSITIVITY DURING THE DEVELOPMENT OF ARTHUS TYPE HYPERSENSITIVITY
por: Salvin, S. B.
Publicado: (1958)

STUDIES ON HYPERSENSITIVITY OF HUMAN TISSUES IN VITRO : I. TUBERCULIN HYPERSENSITIVITY
por: Gangarosa, Eugene J., et al.
Publicado: (1955)

AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia
por: Lehto, Sonya G., et al.
Publicado: (2015)

The Ophthalmology Chief Resident: Does Surgical Volume Correlate With Likelihood of Selection?
por: Richards, Nikisha Q, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t9lojguoqnes9qdu2fbr36vpq2